top of page
My Thoughts
Leveraging my experience as a co-founder of a biotechnology start-up, corporate development leader, and investor to discuss tactical and strategic considerations for building great biotech and pharma companies.
Search
(Don’t Fear) The Partner: Why Signing An Early Strategic Biotech Partnership is Not the Beginning of the End
Here are three common fears regarding early-stage strategic partnerships, and ways a founder or investor can overcome them to be successful.
Drew Hertig, MBA, CLP
Jun 18, 20248 min read
58 views
0 comments
San Diego Life Science Funding Rebounds BIG in Q1 2024, But Will It Last?
Welcome back to biotech beach! Capital raised in Q1 2024 for San Diego-based life science companies jumped 324% from same period last...
Drew Hertig, MBA, CLP
Apr 10, 20243 min read
47 views
0 comments
3 Ways Artificial Intelligence Will Unlock Substantial Value in Drug Development
Artificial Intelligence/Machine Learning (AI/ML) has the potential to significantly lower the costs of drug development and improve...
Drew Hertig, MBA, CLP
Feb 6, 20248 min read
108 views
0 comments
5 Reasons Biotech Valuations Go Down When Inflation Goes Up (and what you can do about it)
Unfortunately for biotechnology companies, their products have long development timelines and are perceived to be a high-risk investment....
Drew Hertig, MBA, CLP
Nov 26, 20238 min read
99 views
0 comments
6 Ways the Covid-19 Pandemic Impacted Cancer Epidemiology in the United States
The COVID-19 pandemic had a significant impact on death rates by demographic groups in many countries, including the United States. These...
Drew Hertig, MBA, CLP
Oct 9, 20233 min read
4 views
0 comments
Top Three Biotech Partnering Drivers for 2023
Biotech stocks have been beat up since February 2021, with the XBI index still down ~50% from record highs Headwinds in 2022 stemming...
Drew Hertig, MBA, CLP
Jan 11, 20234 min read
7 views
0 comments
Small Cap Biotech: When Will the 2021 Bear Market End?
Negative sentiment in the biotech industry has driven the SPDR S&P Biotech ETF (XBI) down more than 30% from February highs....
Drew Hertig, MBA, CLP
Dec 31, 20216 min read
38 views
0 comments
5 Traits Every Entrepreneur Should Have to Maximize Success
Winning a battle is not the same as winning a war. Great entrepreneurs need these five traits to build a sustainable business that...
Drew Hertig, MBA, CLP
Dec 19, 20207 min read
77 views
0 comments
Financial Modeling: 12 Key Steps for Pricing a Pharma Asset
Here are key aspects to consider when evaluating the value of a pharmaceutical platform or asset for continued development, purchase,...
Drew Hertig, MBA, CLP
Oct 31, 20206 min read
137 views
0 comments
bottom of page